Evidence map›Paper›PMID 33419126›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Anticapsular and Antifungal Activity of α-Cyperone.

Connor Horn, Govindsamy Vediyappan

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Essential Oils againstAntibiotics (Basel, Switzerland) · 2024
    Review
  4. Searching for new antifungals for the treatment of cryptococcosis.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Review
  5. Non-Journal of fungi (Basel, Switzerland) · 2022
    Review
  6. Lycorine Alkaloid andMolecules (Basel, Switzerland) · 2022
    Article
  7. Review
  8. Emerging Antifungal Targets and Strategies.International journal of molecular sciences · 2022
    Review
  9. Disease markers · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Connor HornDivision of Biology, Kansas State University, Manhattan, KS 66506, USA.
Govindsamy VediyappanDivision of Biology, Kansas State University, Manhattan, KS 66506, USA.ORCID 0000-0002-0876-9549
Kansas State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections affect 300 million people and cause 1.5 million deaths globally per year. With the number of immunosuppressed patients increasing steadily, there is an increasing number of patients infected with opportunistic fungal infections such as infections caused by the species of

Indexed as

anti-capsuleCandida aurisCandida kruseiCandida spp.Cryptococcus neoformansCyperus rotundusessential oilfluconazole synergyα-Cyperone

Identifiers

PMID33419126
PMCPMC7825567
OpenAlexW3120468192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.